ANALYST RECOMMENDATIONS : Astrazeneca, Biogen, Meta, Netflix, Take-Two, Home Depot...

Every morning, find a selection of analysts' recommendations covering North America and the UK. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information can be used to shed light on movements in certain stocks or on market sentiment towards a company.

• Astrazeneca Plc: ABG Sundal Collier maintains its buy recommendation and raises the target price from 1686 to SEK 1697.
• Biogen Inc.: DZ Bank AG Research maintains its hold recommendation with a price target reduced from USD 300 to USD 242.
• Constellation Software Inc.: Veritas Investment Research maintains its buy recommendation and raises the target price from CAD 3100 to CAD 3300.
• Great-West Lifeco Inc.: Veritas Investment Research upgrades to buy from reduce with a price target raised from CAD 40 to CAD 46.
• Hologic, Inc.: JP Morgan maintains its overweight rating and reduces the target price from USD 95 to USD 85.
• Illumina, Inc.: Canaccord Genuity downgrades to hold from buy with a price target reduced from USD 210 to USD 120.
• Lowe'S Companies, Inc.: Wells Fargo maintains its overweight recommendation and reduces the target price from USD 250 to USD 215.
• Meta Platforms, Inc.: Everbright Securities upgrades to buy from neutral.
• Netflix, Inc.: JP Morgan maintains its overweight rating and raises the target price from USD 480 to USD 510.
• Occidental Petroleum Corporation: Wolfe Research downgrades to peerperform from outperform.
• Take-Two Interactive Software, Inc.: MoffettNathanson LLC upgrades to buy from outperform with a price target raised from USD 165 to USD 169.
• Target Corporation: Telsey Advisory Group maintains its outperform rating and reduces the target price from USD 162 to USD 145.
• The Home Depot, Inc.: Wells Fargo maintains its overweight rating and reduces the target price from USD 360 to USD 340.
• The Trade Desk, Inc.: Morgan Stanley maintains its overweight rating and reduces the target price from USD 105 to USD 70.
• Transdigm Group Inc.: Morningstar upgrades to hold from sell with a price target raised from USD 760 to USD 920.
• Unity Software Inc.: Needham maintains its buy recommendation and reduces the target price from USD 50 to USD 40.
• Veeva Systems Inc.: Barclays maintains its overweight recommendation and reduces the target price from USD 250 to USD 220.